Published in Pharmacol Ther on February 02, 2007
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13
Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience (2008) 1.16
Neuroprotective actions of brain aromatase. Front Neuroendocrinol (2009) 1.14
ent-Steroids: novel tools for studies of signaling pathways. Steroids (2008) 1.12
Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids (2007) 1.02
Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats. Neurobiol Aging (2009) 0.98
Androgens selectively protect against apoptosis in hippocampal neurones. J Neuroendocrinol (2010) 0.96
Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front Neuroendocrinol (2009) 0.96
Impact of estrogen receptor alpha and beta agonists on delayed alternation in middle-aged rats. Horm Behav (2010) 0.95
Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models. Molecules (2010) 0.90
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol (2016) 0.90
Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience (2008) 0.90
Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res (2014) 0.89
Regional variability in age-related loss of neurons from the primary visual cortex and medial prefrontal cortex of male and female rats. Brain Res (2008) 0.88
Postinjury administration of 17β-estradiol induces protection in the gray and white matter with associated functional recovery after cervical spinal cord injury in male rats. J Comp Neurol (2012) 0.86
Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS One (2012) 0.85
Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain Cogn (2009) 0.83
Effects of estrogen on functional and neurological recovery after spinal cord injury: An experimental study with rats. Clinics (Sao Paulo) (2015) 0.83
"All in the mind"? Brain-targeting chemical delivery system of 17β-estradiol (Estredox) produces significant uterotrophic side effect. Pharm Anal Acta (2012) 0.82
A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression. Horm Behav (2010) 0.82
Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease. Evid Based Complement Alternat Med (2013) 0.82
Effects of multiple daily genistein treatments on delayed alternation and a differential reinforcement of low rates of responding task in middle-aged rats. Neurotoxicol Teratol (2011) 0.81
Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia. Int J Mol Sci (2011) 0.81
17α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice. J Alzheimers Dis (2011) 0.80
Quantitative structure-activity relationships predicting the antioxidant potency of 17β-estradiol-related polycyclic phenols to inhibit lipid peroxidation. Int J Mol Sci (2013) 0.78
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury. Neural Regen Res (2015) 0.78
Phenolic compounds protect cultured hippocampal neurons against ethanol-withdrawal induced oxidative stress. Int J Mol Sci (2009) 0.78
Retracted Estrogens and neuroprotection in retinal diseases. Mol Vis (2008) 0.77
Non-Feminizing Estrogens Do Not Exhibit Antidepressant-like Activity. J Pharm Drug Res (2016) 0.75
The free radical theory of aging matures. Physiol Rev (1998) 9.83
A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (2005) 9.80
Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov (2004) 5.82
Oxidative stress and neurodegeneration: where are we now? J Neurochem (2006) 5.44
Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol (1997) 5.43
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (2000) 4.92
The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem (2001) 4.67
Direct observation of a free radical interaction between vitamin E and vitamin C. Nature (1979) 2.91
Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab (1997) 2.73
Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (1985) (2001) 2.33
Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol (1997) 2.16
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med (2002) 2.05
Oestrogen as a neuroprotective hormone. Nat Rev Neurosci (2002) 2.03
Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol (2005) 1.97
Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci U S A (1995) 1.92
Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab (2003) 1.90
Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A (2003) 1.87
17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol (2005) 1.80
17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun (1995) 1.80
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids (1997) 1.80
The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci (1999) 1.76
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol (2000) 1.69
Hormone therapy: physiological complexity belies therapeutic simplicity. Science (2004) 1.68
Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol (1985) (2001) 1.68
The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A (1999) 1.56
Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci (2001) 1.46
Antiinflammatory effects of estrogen on microglial activation. Endocrinology (2000) 1.44
Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol (2005) 1.42
Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci (2001) 1.42
17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell (2005) 1.41
From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res (2005) 1.40
Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience (2005) 1.38
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37
Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep (2001) 1.37
Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol (2006) 1.36
Oxidative stress: free radical production in neural degeneration. Pharmacol Ther (1994) 1.33
Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem (2004) 1.31
Evidence for the colocalization of estrogen receptor-beta mRNA and estrogen receptor-alpha immunoreactivity in neurons of the rat forebrain. Endocrinology (1998) 1.25
Antioxidant properties of steroids. J Steroid Biochem Mol Biol (1993) 1.24
Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci (2001) 1.23
Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis (2006) 1.22
17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci (1997) 1.20
Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology (2003) 1.19
Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res (2002) 1.18
Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16
17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J Neurosci Res (2004) 1.13
Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport (1998) 1.12
Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol (1998) 1.10
Estrogen-like compounds for ischemic neuroprotection. Stroke (2004) 1.10
Gonadal hormones and sex differences in pain reactivity. Clin J Pain (2003) 1.09
Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord (2005) 1.08
Comparative QSAR analysis of estrogen receptor ligands. Chem Rev (1999) 1.07
Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab (1993) 1.06
Region- and peptide-specific regulation of the neurotrophins by estrogen. Brain Res Mol Brain Res (2000) 1.03
Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain. Neuroscience (2000) 1.02
Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I. Headache (2006) 1.02
Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res (2005) 1.01
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev (2001) 1.01
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels. Am J Physiol Heart Circ Physiol (2003) 1.00
The catechol estrogens. J Steroid Biochem (1981) 0.98
Estrogen A-ring structure and antioxidative effect on lipoproteins. J Steroid Biochem Mol Biol (2005) 0.97
Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience (1998) 0.96
17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience (2005) 0.95
17-beta-estradiol induces an inhibitor of active caspases. J Neurosci (2001) 0.95
Estrogen modulation of the cyclic AMP response element-binding protein pathway. Effects of long-term and acute treatments. Neuroendocrinology (2001) 0.94
Coregulators of estrogen receptor action. Crit Rev Eukaryot Gene Expr (2002) 0.93
A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol (1998) 0.93
Synthesis and biological evaluation of 17beta-alkoxyestra-1,3, 5(10)-trienes as potential neuroprotectants against oxidative stress. J Med Chem (2001) 0.91
Lipoprotein-associated estrogens. Cardiovasc Res (2002) 0.90
Estrogen regulates bcl-x expression in rat hippocampus. Neuroreport (2001) 0.89
In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids (1996) 0.89
Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem (1999) 0.89
Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Ann N Y Acad Sci (2005) 0.88
Membrane fluidity effects of estratrienes. Brain Res Bull (2001) 0.86
Estrogen and the brain: beyond ER-alpha and ER-beta. Exp Gerontol (2004) 0.86
Estrogen receptor immunoreactivity in the adult primate brain: neuronal distribution and association with p75, trkA, and choline acetyltransferase. J Comp Neurol (1999) 0.86
Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands. J Chem Inf Comput Sci (1999) 0.82
Endogenously expressed estrogen receptors mediate neuroprotection in hippocampal cells (HT22). J Cell Biochem (2005) 0.82
Estrogen-induced changes in the microtubular system correlate with a decreased susceptibility of aging neurons to beta amyloid neurotoxicity. Mol Cell Neurosci (2003) 0.80
Untangling the human estrogen receptor gene structure. J Neural Transm (Vienna) (2002) 0.80
Effect of 17-beta-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats. Toxicology (2004) 0.79
Influence of estrogen replacement therapy on plasma lipid peroxidation. Menopause (2001) 0.79
Oral ascorbic acid increases plasma oestradiol during postmenopausal hormone replacement therapy. Maturitas (2002) 0.79
Effects of estrogens on the redox chemistry of iron: a possible mechanism of the antioxidant action of estrogens. Steroids (1995) 0.79
Evidence that alpha-tocopherol functions cyclically to quench free radicals in hepatic microsomes. Requirement for glutathione and a heat-labile factor. Ann N Y Acad Sci (1989) 0.78
Estrogen regulates neurofilament gene expression in adult female rat dorsal root ganglion neurons. Exp Neurol (1997) 0.78
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron (2007) 3.98
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell (2013) 1.71
Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res (2004) 1.59
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem (2011) 1.41
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37
Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol (1985) (2002) 1.35
Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res (2004) 1.29
Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci (2008) 1.25
Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc Natl Acad Sci U S A (2008) 1.22
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta (2006) 1.20
17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res (2005) 1.18
Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16
Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci (2003) 1.15
Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) (2006) 1.09
Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci (2003) 1.09
Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res (2004) 1.08
Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem (2004) 1.07
Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol (2006) 1.06
Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci (2003) 1.05
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem (2009) 1.02
Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther (2009) 1.02
Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids (2007) 1.02
Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity. J Neurochem (2015) 1.01
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res (2007) 0.99
Neuroprotective actions of methylene blue and its derivatives. PLoS One (2012) 0.99
Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp Eye Res (2004) 0.97
Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Neurosci Lett (2007) 0.96
Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. J Neurochem (2007) 0.96
Role of protein phosphatases in estrogen-mediated neuroprotection. J Neurosci (2005) 0.95
The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann N Y Acad Sci (2003) 0.95
The effect of atrazine administered by gavage or in diet on the LH surge and reproductive performance in intact female Sprague-Dawley and Long Evans rats. Birth Defects Res B Dev Reprod Toxicol (2014) 0.93
Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology (2011) 0.92
Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. Eur J Pharmacol (2003) 0.91
Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. J Neurobiol (2005) 0.91
Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord (2005) 0.91
An okadaic acid-induced model of tauopathy and cognitive deficiency. Brain Res (2010) 0.90
Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation. J Pharmacol Exp Ther (2007) 0.89
Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms. J Neurol Sci (2002) 0.89
Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett (2005) 0.88
Estradiol protects against cerebellar damage and motor deficit in ethanol-withdrawn rats. Alcohol (2002) 0.88
Ethanol withdrawal posttranslationally decreases the activity of cytochrome c oxidase in an estrogen reversible manner. Neurosci Lett (2007) 0.88
Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner. Brain Res (2010) 0.87
Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J Neuroinflammation (2009) 0.87
The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res (2010) 0.87
Estrone is neuroprotective in rats after traumatic brain injury. J Neurotrauma (2012) 0.87
Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model. Neurobiol Dis (2013) 0.86
Estrogen protects against brain lipid peroxidation in ethanol-withdrawn rats. Pharmacol Biochem Behav (2004) 0.86
Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radic Biol Med (2005) 0.85
Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS One (2012) 0.85
Ethanol withdrawal acts as an age-specific stressor to activate cerebellar p38 kinase. Neurobiol Aging (2010) 0.85
Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues. Brain Res (2010) 0.84
Noninvasive monitoring of estrogen effects against ischemic stroke in rats by near-infrared spectroscopy. Appl Opt (2007) 0.84
Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology (2008) 0.84
Modulation of polymorphonuclear neutrophil functions by astrocytes. J Neuroinflammation (2010) 0.84
Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem (2008) 0.83
Neuroprotective effects of high affinity Σ1 receptor selective compounds. Brain Res (2011) 0.83
17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Res (2003) 0.83
An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation. ACS Chem Neurosci (2012) 0.82
Therapeutic strategies in Friedreich's ataxia. Brain Res (2013) 0.82
Quinol-based metabolic cycle for estrogens in rat liver microsomes. Drug Metab Dispos (2003) 0.82
nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells. Neuroreport (2004) 0.82
Role of the GABA-A system in estrogen-induced protection against brain lipid peroxidation in ethanol-withdrawn rats. Alcohol Clin Exp Res (2004) 0.81
Hippocampal progenitor cells express nestin following cerebral ischemia in rats. Neuroreport (2005) 0.81
Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci (2012) 0.81
Ethanol withdrawal hastens the aging of cytochrome c oxidase. Neurobiol Aging (2011) 0.81
Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation (2007) 0.81
Involvement of estrogen receptor β5 in the progression of glioma. Brain Res (2013) 0.81
Role of the GABAA system in behavioral, motoric, and cerebellar protection by estrogen during ethanol withdrawal. Alcohol (2003) 0.81
Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J Appl Physiol (1985) (2008) 0.81
Correspondence regarding Schwend and Gustafsson, "False positives in MALDI-TOF detection of ERbeta in mitochondria". Biochem Biophys Res Commun (2006) 0.80
A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells. J Pharmacol Exp Ther (2006) 0.80
A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders. Chem Commun (Camb) (2013) 0.80
Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner. J Bioenerg Biomembr (2008) 0.80
Role of parvalbumin in estrogen protection from ethanol withdrawal syndrome. Alcohol Clin Exp Res (2005) 0.80
Role of protein kinase C in estrogen protection against apoptotic cerebellar cell death in ethanol-withdrawn rats. Alcohol (2003) 0.80
Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther (2008) 0.79
Increased severity of acute cerebral ischemic injury correlates with enhanced stem cell induction as well as with predictive behavioral profiling. Curr Neurovasc Res (2004) 0.79
Simultaneous quantification of four native estrogen hormones at trace levels in human cerebrospinal fluid using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2010) 0.79
Phenolic compounds protect cultured hippocampal neurons against ethanol-withdrawal induced oxidative stress. Int J Mol Sci (2009) 0.78
Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003. J Womens Health (Larchmt) (2004) 0.78
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Brain Res (2013) 0.78
Alkaloids from the hook-bearing branch of Uncariarhynchophylla and their neuroprotective effects against glutamate-induced HT22 cell death. J Asian Nat Prod Res (2014) 0.77
Retracted Estrogens and neuroprotection in retinal diseases. Mol Vis (2008) 0.77
Estrogen-induced signaling attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity. Brain Res (2011) 0.77
Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells. J Alzheimers Dis (2010) 0.77
R- and S-equol have equivalent cytoprotective effects in Friedreich's ataxia. BMC Pharmacol Toxicol (2012) 0.76
Suppression of protein kinase Cepsilon mediates 17beta-estradiol-induced neuroprotection in an immortalized hippocampal cell line. J Neurochem (2005) 0.76
Potential testosterone therapy for hypogonadal sexual dysfunction in women. J Womens Health (Larchmt) (2005) 0.75
A Paper-based Surface-Enhanced Raman Scattering Lateral Flow Strip for Detection of Neuron-Specific Enolase in Blood Plasma. Anal Chem (2017) 0.75
Ethanol withdrawal reduces cerebellar parvalbumin expression in a manner reversed by estrogens. Neurosci Lett (2004) 0.75
Investigation of the temperature stability of premarin intravenous using liquid chromatography-mass spectrometry. J Pharm Biomed Anal (2011) 0.75
Menopausal Vasomotor Symptoms (MVS) survey for assessment of hot flashes. J Womens Health (Larchmt) (2006) 0.75
Retention behavior of estrogen metabolites on hydrophilic interaction chromatography stationary phases. J Sep Sci (2010) 0.75